Trial Profile
A trial of natalizumab in multiple sclerosis patients with high active disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Natalizumab (Primary)
- Indications Sclerosis
- Focus Therapeutic Use
- 07 Dec 2015 New trial record